Oral N-acetylcysteine rescues lethality of hepatocyte-specific Gclc-knockout mice, providing a model for hepatic cirrhosis.
Oral N-acetylcysteine rescues lethality of hepatocyte-specific Gclc-knockout mice, providing a model for hepatic cirrhosis.
复制标题
DOI:
10.1016/j.jhep.2010.05.028
复制
发表时间:
2010-12
影响因子:
25.7
通讯作者:
Dalton TP
中科院分区:
文献类型:
--
作者:
Chen Y;Johansson E;Yang Y;Miller ML;Shen D;Orlicky DJ;Shertzer HG;Vasiliou V;Nebert DW;Dalton TP
Certain liver diseases have been associated with depletion of glutathione (GSH), the major antioxidant in liver. A recent report about Gclch/h mice having a hepatocyte-specific ablation of Gclc (the gene encoding the catalytic subunit of the rate-limiting enzyme in GSH synthesis) has shown an essential role of GSH in hepatic function. Gclch/h mice develop severe steatosis and die of liver failure within one month, due to ~95% depletion of hepatic GSH; mitochondria are the major affected organelles, displaying abnormal ultrastructure and impaired function. Gclch/h mice were fed with L-N-acetylcysteine (NAC; 10 g/L) in drinking water starting at postnatal day 18. Gclch/h mice were rescued by NAC supplementation to adulthood. NAC replenished the mitochondrial GSH pool and attenuated mitochondrial damage, accompanied with diminished hepatic steatosis; however, abnormal liver biochemical tests, hepatocytes death and hepatic oxidative stress persisted in the rescued mice. At age 50 days, the liver from rescued Gclch/h mice started to display characteristics of fibrosis, and at age 120 days, macronodular cirrhosis was observed. Immunohistostaining for liver-specific markers and the expression profile of hepatic cytokines indicated that the repopulation of hepatocytes in the cirrhotic nodules involves the expansion of oval cells. Replenishment of mitochondrial GSH and restoration of mitochondrial function by NAC prevent mortality caused by loss of hepatocyte GSH de novo synthesis, allowing the progression of steatosis to a chronic stage. Thus, with NAC supplementation, Gclch/h mice provide a model for the development of liver fibrosis and cirrhosis.
登录
查看更多内容
影响因子:
3.2
作者:
Day, CP
通讯作者:
Day, CP
影响因子:
15.9
作者:
Leclercq, IA;Farrell, GC;Robertson, GR
通讯作者:
Robertson, GR
影响因子:
7.4
作者:
Circu, Magdalena L.;Rodriguez, Cynthia;Aw, Tak Yee
通讯作者:
Aw, Tak Yee
影响因子:
5.1
作者:
Lash, Lawrence H.
通讯作者:
Lash, Lawrence H.
影响因子:
2.9
作者:
Senft, AP;Dalton, TP;Shertzer, HG
通讯作者:
Shertzer, HG